New discovery may explain how certain cancers develop
May 28th, 2010 - 12:51 pm ICT by ANIWashington, May 28 (ANI): A new discovery made by a Florida State University College of Medicine researcher may help explain how certain cancers develop.
Yoichi Kato, an assistant professor in the Department of Biomedical Sciences, and his lab team found discovered a new interaction between a cell signaling system and a specific gene that may be the cause of B-cell lymphoma.
The finding suggests a similar interaction could be occurring during the development of other types of cancer, leading to further understanding of how cancer works - and how it might be stopped.
The researchers found that the gene - known in scientific shorthand as BCL6 - can inhibit one of the pathways cells use to transmit signals to other cells. Called the Notch signaling pathway, it’s an important mechanism for cells to control gene regulation.
“There are very few molecules that we know directly inhibit Notch signalling. So that is why the interaction, and our finding, is very interesting to people in many areas - cancer specialists, neuroscientists, and many others,” Kato said.
The researchers have focused on the Notch signaling pathway’s role in vertebrate early development. In their study, they found that when BCL6 inhibits the Notch signaling pathway during the early stages of embryo development, the alignment of the embryo’s internal organs is affected, which can lead to a congenital disorder.
However, the Notch signaling pathway, which creates the equivalent of a molecular highway across a cell’s membrane, is involved in many types of cell-to-cell interaction, including neuron development, stem cell differentiation and apoptosis (programmed cell death).
The fact that BCL6 regulates the Notch signaling pathway could be important for any cellular process where Notch plays a role, including the formation of many cancers. BCL6 is a gene that, when mutated in certain ways, can lead to several types of B-cell lymphoma.
B-cell lymphomas, including both Hodgkin’s and non-Hodgkin’s lymphomas, occur when B-cells, which produce antibodies to fight infections, mutate and become cancerous.
With more study of the interaction between the Notch signaling pathway and the BCL6 gene, scientists may be able to better understand how these cancers form.
Kato and his lab plan to further investigate the interaction’s role in neural development, as well as how the interaction could affect stem cell formation.
The findings were published in the journal Developmental Cell, and Kato recently presented the paper at an international conference in Cold Spring Harbor, N.Y. (ANI)
- New drug type developed to kill lymphoma cells - May 11, 2010
- 'Junk' DNA behind cancer growth - May 03, 2010
- Factor boosting leukemia's aggressiveness identified - Oct 23, 2010
- Seaweed extract may help treat lymphoma - Mar 11, 2010
- Discovery of key pathway interaction paves way for brain growth therapies - Sep 17, 2010
- Novel therapeutic target for non-Hodgkin's lymphoma identified - Nov 23, 2009
- Compound that kills lymphoma cells discovered - Apr 13, 2010
- New path discovered for colon cancer drug discovery - Nov 20, 2010
- Boffins design new class of drug that kills lymphoma cells - Apr 15, 2010
- Protein discovery could lead to better autoimmune disease, cancer drugs - Mar 03, 2011
- Scientists develop new method to produce natural killer cells for cancer - Jun 11, 2010
- Full genetic blueprint of blood cancer offers new insights - Mar 24, 2011
- Gene that prevents stem cells from turning cancerous identified - Oct 15, 2010
- How two proteins fuse together to trigger cancer - Jan 28, 2011
- New hope in the fight against melanoma - Dec 14, 2010
Tags: b cell lymphoma, cancer specialists, cell interaction, cell lymphomas, college of medicine, congenital disorder, florida state university, florida state university college, florida state university college of medicine, gene regulation, internal organs, medicine researcher, new discovery, notch signaling pathway, programmed cell death, signaling system, stages of embryo development, stem cell differentiation, types of cancer, yoichi kato